Fanconi Anemia Complementation Group V C4310652
A subtype of Fanconi anemia involving defective DNA repair. Patients may develop bone marrow failure, physical abnormalities, and have higher cancer risk. Management involves monitoring and transplant consideration.
Key facts at a glance
- ICD-10
- D61.03
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Bone marrow failure
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Fatigue
(hematologic)Renal anomalies
(hematologic)Congenital heart defect
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Hematopoietic Stem Cell Transplantation
Established curative approach for hematopoietic failure using matched sibling or unrelated donor stem cells. Pre-transplant conditioning must balance efficacy with toxicity in patients with congenital abnormalities.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Androgen and Growth Factor Combination
Combined androgen therapy with hematopoietic growth factors to maximize blood count improvement. Requires careful monitoring for hepatic and lipid abnormalities.
Additional treatment options
Leukemia Transformation Surveillance
Frequent bone marrow assessments with cytogenetic analysis to detect progression to myelodysplastic syndrome or acute leukemia. Earlier intervention improves outcomes when transformation occurs.
monitoringIron Chelation Management
Treatment of transfusional iron overload through chelation therapy protecting cardiac, hepatic, and endocrine organs. Serum ferritin and organ function monitoring guide therapy duration.
dietaryGenetic Counseling and Family Support
Comprehensive genetic counseling for affected patients and family members regarding inheritance patterns, carrier testing options, and reproductive planning considerations.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Fanconi Anemia Complementation Group V C4310652?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Fanconi Anemia Complementation Group V C4310652. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy